Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results Director departure
|
GENOCEA BIOSCIENCES, INC. (GNCA)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/03/2022 |
4
| Duvall Diantha (CFO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 1,355 shares
@ $0.06, valued at
$81.3 |
|
06/03/2022 |
4
| Flechtner Jessica Baker (Chief Scientific Officer) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 1,578 shares
@ $0.06, valued at
$94.7 |
|
06/03/2022 |
4
| Clark William D (President and CEO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 4,023 shares
@ $0.06, valued at
$241.4 |
|
06/02/2022 |
4
| SUMER JACQUELYN L (CHIEF LEGAL & COMPLIANCE OFF) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 2,500 shares
@ $0.0601, valued at
$150.3 |
|
06/02/2022 |
4
| Clark William D (President and CEO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 117,244 shares
@ $0.0617, valued at
$7.2k
|
|
06/01/2022 |
4
| Siber George (Director) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 20,425 shares
@ $0.0653, valued at
$1.3k
|
|
05/26/2022 |
4
| Walker Paul Edward (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 5,931,843 shares
@ $0.0654, valued at
$387.9k
Sold 4,445,093 shares
@ $0.0816, valued at
$362.7k
|
|
05/26/2022 |
4
| Sonsini Peter W. (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 5,931,843 shares
@ $0.0654, valued at
$387.9k
Sold 4,445,093 shares
@ $0.0816, valued at
$362.7k
|
|
05/26/2022 |
4
| SANDELL SCOTT D (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 5,931,843 shares
@ $0.0654, valued at
$387.9k
Sold 4,445,093 shares
@ $0.0816, valued at
$362.7k
|
|
05/26/2022 |
4
| New Enterprise Associates 16, L.P. (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 5,931,843 shares
@ $0.0654, valued at
$387.9k
Sold 4,445,093 shares
@ $0.0816, valued at
$362.7k
|
|
05/26/2022 |
4
| Makhzoumi Mohamad (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 5,931,843 shares
@ $0.0654, valued at
$387.9k
Sold 4,445,093 shares
@ $0.0816, valued at
$362.7k
|
|
05/26/2022 |
4
| Florence Anthony A. Jr. (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 5,931,843 shares
@ $0.0654, valued at
$387.9k
Sold 4,445,093 shares
@ $0.0816, valued at
$362.7k
|
|
05/26/2022 |
4
| Chang Carmen (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 5,931,843 shares
@ $0.0654, valued at
$387.9k
Sold 4,445,093 shares
@ $0.0816, valued at
$362.7k
|
|
05/26/2022 |
4
| Behbahani Ali (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 5,931,843 shares
@ $0.0654, valued at
$387.9k
Sold 4,445,093 shares
@ $0.0816, valued at
$362.7k
|
|
05/26/2022 |
4
| BASKETT FOREST (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 5,931,843 shares
@ $0.0654, valued at
$387.9k
Sold 4,445,093 shares
@ $0.0816, valued at
$362.7k
|
|
05/26/2022 |
4
| Flechtner Jessica Baker (Chief Scientific Officer) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 16,525 shares
@ $0.0881, valued at
$1.5k
|
|
05/26/2022 |
4
| Duvall Diantha (CFO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 24,407 shares
@ $0.0765, valued at
$1.9k
|
|
04/05/2022 |
4
| Flechtner Jessica Baker (Chief Scientific Officer) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 1,212 shares
@ $1.25, valued at
$1.5k
|
|
04/05/2022 |
4
| Duvall Diantha (CFO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 963 shares
@ $1.25, valued at
$1.2k
|
|
04/05/2022 |
4
| Davis Thomas Andrew (CHIEF MEDICAL OFFICER) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 1,091 shares
@ $1.25, valued at
$1.4k
|
|
04/05/2022 |
4
| Clark William D (President and CEO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 3,924 shares
@ $1.25, valued at
$4.9k
|
|
04/05/2022 |
4
| Aakalu Girish N (CHIEF BUSINESS OFFICER) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 963 shares
@ $1.25, valued at
$1.2k
|
|
03/17/2022 |
4
| SUMER JACQUELYN L (CHIEF LEGAL & COMPLIANCE OFF) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Granted 37,500 shares
@ $0 Granted 112,500 options to buy
@ $1.11, valued at
$124.9k
|
|
03/17/2022 |
4
| STAPLETON RAYMOND D JR (CHIEF TECHNOLOGY OFFICER) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Granted 43,750 shares
@ $0 Granted 131,250 options to buy
@ $1.11, valued at
$145.7k
|
|
03/17/2022 |
4
| Flechtner Jessica Baker (Chief Scientific Officer) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Granted 43,750 shares
@ $0 Sold 3,349 shares
@ $1.1, valued at
$3.7k
Granted 131,250 options to buy
@ $1.11, valued at
$145.7k
|
|
03/17/2022 |
4
| Duvall Diantha (CFO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Granted 37,500 shares
@ $0 Sold 2,873 shares
@ $1.1, valued at
$3.2k
Granted 112,500 options to buy
@ $1.11, valued at
$124.9k
|
|
03/17/2022 |
4
| Davis Thomas Andrew (CHIEF MEDICAL OFFICER) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Granted 31,250 shares
@ $0 Sold 2,717 shares
@ $1.1, valued at
$3k
Granted 93,750 options to buy
@ $1.11, valued at
$104.1k
|
|
03/17/2022 |
4
| Clark William D (President and CEO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Granted 150,000 shares
@ $0 Sold 11,435 shares
@ $1.1, valued at
$12.6k
Granted 450,000 options to buy
@ $1.11, valued at
$499.5k
|
|
03/17/2022 |
4
| Aakalu Girish N (CHIEF BUSINESS OFFICER) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Granted 31,250 shares
@ $0 Sold 2,397 shares
@ $1.1, valued at
$2.6k
Granted 93,750 options to buy
@ $1.11, valued at
$104.1k
|
|
03/07/2022 |
4
| Lunger John (Director) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Granted 30,000 options to buy
@ $1.06, valued at
$31.8k
|
|
09/28/2021 |
4
| Herron Jennifer Lyn (Director) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Granted 30,000 options to buy
@ $2.02, valued at
$60.6k
|
|
07/02/2021 |
4
| Behbahani Ali (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Granted 15,000 options to buy
@ $2.33, valued at
$35k
|
|
07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/02/2021 |
4
| Siber George (Director) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Granted 15,000 options to buy
@ $2.33, valued at
$35k
|
|
|
|
|